A Study to Evaluate the Effect of Single Oral Dose of Balinatunfib on Cardiac Repolarization in Healthy Adult Participants.

NCT07272629 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Cardiac Repolarization
Healthy Volunteers

Interventions

DRUG: Balinatunfib
DRUG: Moxifloxacin
DRUG: Placebo

Sponsor

Sanofi